Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQB3126 in Advanced Breast Cancer
NCT07697443Phase 2Recruiting
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Sep 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 2 trial of TQB3126 in breast cancer, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Sep 2026; status: recruiting.
02
Drugs
TQB3126
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07697443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07697443.